
Genfit S.A. GNFTF
GNFTF
Genfit S.A. IPHYF
Innate Pharma S.A. BXPHF
Botanix Pharmaceuticals Limited JWCTF
JW (Cayman) Therapeutics Co. Ltd BRIBF
Brii Biosciences Limited NDTP
NDT Pharmaceuticals Inc. PRNAF
Alterity Therapeutics Limited SPHDF
Santhera Pharmaceuticals Holding AG SLNCF
Silence Therapeutics plc BOVNF
BioInvent International AB (publ)
Genfit S.A. IPHYF
Innate Pharma S.A. BXPHF
Botanix Pharmaceuticals Limited JWCTF
JW (Cayman) Therapeutics Co. Ltd BRIBF
Brii Biosciences Limited NDTP
NDT Pharmaceuticals Inc. PRNAF
Alterity Therapeutics Limited SPHDF
Santhera Pharmaceuticals Holding AG SLNCF
Silence Therapeutics plc BOVNF
BioInvent International AB (publ)
Performance
Periode | GNFTF | IPHYF | BXPHF | JWCTF | BRIBF | NDTP | PRNAF | SPHDF | SLNCF | BOVNF |
---|---|---|---|---|---|---|---|---|---|---|
6M | 5.08 % | 37.93 % | -59.78 % | 179.20 % | -7.46 % | 1 540.51 % | -32.04 % | -25.38 % | 68.42 % | -30.03 % |
YTD | 5.08 % | -31.03 % | -71.09 % | 179.20 % | 91.79 % | 2 069.81 % | 94.44 % | 30.31 % | -39.16 % | -30.03 % |
1Y | -32.97 % | -10.71 % | -56.47 % | 77.37 % | 91.79 % | 1 361.25 % | 94.44 % | 4.91 % | -73.77 % | -30.03 % |
3Y | 1.64 % | -3.38 % | 516.67 % | 18.31 % | -62.98 % | 23 621.12 % | -12.50 % | -99.13 % | 21.21 % | -30.03 % |
5Y | -13.08 % | -49.87 % | 23.33 % | -84.13 % | -91.25 % | -72.62 % | -84.75 % | 345 774 547.89 % | -67.68 % | -28.78 % |
10Y | -91.15 % | -87.06 % | -53.75 % | -84.13 % | -91.25 % | 15.00 % | -94.81 % | 1 147 196 261 582.24 % | -50.77 % | -63.86 % |
Depuis le début | -87.06 % | -87.12 % | -53.75 % | -84.13 % | -91.25 % | -99.77 % | -97.41 % | 27 277 777 677.78 % | -36.00 % | -50.17 % |